teladoc glp-1 expands provider-based program to prediabetes, weight management as demand surges for weight loss drugs Online Weight Management Program |

Ethics declarations Competing interests All authors declare no competing interests

By Type The GLP-1 receptor agonist market is segmented by drug class into: a) Liraglutide b) Semaglutide c) Tirzepatide d) Dulaglutide e) Other Drugs By Route Of Administration The GLP-1 receptor agonist market is segmented by route of administration into: a) Parenteral b) Oral By End-User The GLP-1 receptor agonist market is segmented by end-user into: a) Hospitals b) Surgical Clinics c) Other End-Users By Geography - The GLP-1 receptor agonist market is segmented by geography into: China India Japan Australia Indonesia South Korea USA Canada Brazil France Germany UK Italy Spain Russia o Asia Pacific o Africa GLP-1 Receptor Agonist Market Drivers The key drivers of the GLP-1 receptor agonist market include: Rise In Obesity Rates During the forecast period, the rise in obesity rates will propel the growth of the GLP-1 receptor agonist market

Benefits of Selank Selank shows potential for a range of medical applications

De Caprio, C

Transl Neurodegener 14(1):10 Trofin D-M et al (2025) Oxidative stress in brain function